Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with low‐grade endometrioid endometrial cancer: A systematic review and head‐to‐head meta‐analysis
Journal of Clinical Ultrasound · 2023
DOI: 10.1002/jcu.23508 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Ultrasound, 2023. Verfasst von Sara Tameish und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital Sant Joan, Reus, Spain. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
We aimed to compare the diagnostic performance of magnetic resonance imaging (MRI) and transvaginal ultrasound (TVS) for detecting myometrial invasion (MI) in patients with low‐grade endometrioid endometrial carcinoma.
Methods
A comprehensive search of MEDLINE (Pubmed), Web of Science, Embase and Scopus (from January 1990 to December 2022) was performed for articles comparing TVS and MRI in the evaluation of myometrial infiltration in low‐grade (grade 1 or 2) endometrioid endometrial carcinoma in the same group of patients. We used QUADAS‐2 tool for assessing the risk of bias of studies.
Results
We found 104 citations in our extensive research. Four articles were ultimately included in the meta‐analysis, after excluding 100 reports. All articles were considered low risk of bias in most of the domains assessed in QUADAS‐2. We observed that pooled sensitivity and specificity for detecting deep MI were 65% (95% confidence interval [CI] = 54%–75%) and 85% (95% CI = 79%–89%) for MRI, and 71% (95% CI = 63%–78%) and 76% (95% CI = 67%–83%) for TVS, respectively. No statistical differences were found between both imaging techniques ( p > 0.05). We observed low heterogeneity for sensitivity and high for specificity regarding TVS; and moderate for both sensitivity and specificity in case of MRI.
Conclusions
The diagnostic performance of TVS and MRI for the evaluation of deep MI in women with low‐grade endometrioid endometrial cancer is similar. However, further research is needed as the number of studies is scanty.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University Hospital Sant Joan, Reus, Spain.
- Department of Obstetrics and Gynecology, University Hospital Virgen de Valme, Seville, Spain.
- Department Obstetrics and Gynecology, University Hospital Virgen de la Arrixaca, Murcia, Spain.
- Department of Obstetrics and Gynecology, University Hospital Castelló, Castelló de la Plana, Spain.
- Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
ORCID-Profile: Juan Luis Alcázar
Zitieren
APA
Tameish, S., Florez, N., Vidal, J. R. P., Chen, H., Vara, J., & Alcázar, J. L. (2023). Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with low‐grade endometrioid endometrial cancer: A systematic review and head‐to‐head meta‐analysis. Journal of Clinical Ultrasound. https://doi.org/10.1002/jcu.23508
Vancouver
Tameish S, Florez N, Vidal JRP, Chen H, Vara J, Alcázar JL. Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with low‐grade endometrioid endometrial cancer: A systematic review and head‐to‐head meta‐analysis. Journal of Clinical Ultrasound. 2023. doi:10.1002/jcu.23508
BibTeX
@article{Tameish2023,
author = {Tameish, Sara and Florez, Natalia and Vidal, Juan Ramón Pérez and Chen, Hui and Vara, Julio and Alcázar, Juan Luis},
title = {Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with low‐grade endometrioid endometrial cancer: A systematic review and head‐to‐head meta‐analysis},
journal = {Journal of Clinical Ultrasound},
year = {2023},
doi = {10.1002/jcu.23508}
}
EUVIMED